PLZB News Alert Plaza Bank [Ca] (PLZB) 3.0400 09/26/2014 11:

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Plaza Bank [Ca] (PLZB) 3.0400 $PLZB

Plaza Bank Continues to Grow Their Talent Pool With New Hires
Marketwire - Tue Aug 19, 7:31PM CDT
Plaza Bank (OTCBB: PLZB) announces the addition of Greg Janes, Relationship Manager, and Michael Kobzeff, Information Technology Manager, to the bank. Both Janes and Kobzeff will be working in the Irvine location.

Plaza Bank Continues Momentum, Growth and Evolution
Marketwire - Mon Jul 07, 8:00PM CDT
Plaza Bank (OTCBB: PLZB) is enjoying another year of solid performance and expansion.

Plaza Bank Strengthens Talent With New HR Executive
Marketwire - Thu Jul 03, 6:31PM CDT
Plaza Bank (OTCBB: PLZB) (the "Bank" has further solidified its management team with the hiring of Amy Yeager as Vice President and Human Resources Business Partner.

Plaza Bank Completes $4.2MM Stock Offering
Business Wire - Thu Jul 03, 2:18PM CDT
Plaza Bank (OTCBB ZBW) announced today that it has completed a stock offering raising $4.2 million from individual investors. George Armendariz, Chairman of Plaza Bank, stated that "the new capital will allow the Bank to expand relationships with our existing clients, and allows us to serve a broader range of clients in the Puget Sound area." Michael Paul, President and CEO, added, "Our growth strategy is aimed at commercial enterprise, professional firms and not-for-profit organizations. We offer a full service integrated organization with treasury management, strong communication and a growing Delivery Culture, emphasizing the satisfaction of clients. To this end, we will be adding to our team to facilitate our anticipated growth."

Plaza Bank Adds More Commercial Strength With Return of Talented Exec
Marketwire - Tue Mar 25, 7:31AM CDT
Plaza Bank (OTCBB: PLZB) added more strength to its expert team serving small and midsize businesses with the return of experienced banker Chris Rabenold as a vice president and business development officer.

Plaza Bank Hits $500 Million in Assets
Marketwire - Thu Feb 27, 7:04AM CST
Plaza Bank (OTCBB: PLZB) (the "Bank" announced today that it has surpassed the $500 million mark in assets (unaudited). A great accomplishment for community banks today, Plaza continues to grow and thrive in this changing economy. Since the beginning of 2014, the Bank has not only added 10 additional staff to support growth, it has also promoted 5 leaders from within to support their continuing success.

Plaza Bank Announces Financial Results for the Year and Quarter Ended December 31, 2013
Marketwire - Thu Jan 23, 7:45AM CST
Plaza Bank (OTCBB: PLZB) (the "Bank" reported unaudited net income for the year ended December 31, 2013 was $5.2 million or $0.30 per share on a diluted basis, a $2.8 million, or 118%, increase compared to the same period in 2012 of $2.4 million or $0.14 per share on a diluted basis. For the year ended December 31, 2013, the Bank's return on average assets was 1.16% and return on average equity was 10.05%, up from a return on average assets of 0.63% and a return on average equity of 5.00% for 2012.

Plaza Bank Reports Improved Earnings
Marketwire - Tue Jul 23, 9:17PM CDT
Plaza Bank (OTCQB: PLZB) (the "Bank" reported unaudited net income for the three months ended June 30, 2013 of $1,637,000 or $0.09 per share on a diluted basis, a 150% increase from the second quarter of 2012 of $656,000 or $0.04 per share on a diluted basis. For the three months ended June 30, 2013, Plaza Bank's return on average assets was 1.51% and return on average equity was 12.8%, up from a return on average assets of 0.70% and a return on average equity of 5.57% for the comparable period of 2012.

Plaza Bank Adds to Accomplished Banking Team as It Grows and Thrives
Marketwire - Mon Jul 15, 5:45PM CDT
Plaza Bank (OTCBB: PLZB), which is becoming an industry model for strong community banking, strengthened its small and midsize business services and expertise yet again with an array of top-notch hires and promotions.

Plaza Bank Acquires Assets and Deposits of 1st Commerce Bank From the FDIC
Marketwire - Thu Jun 06, 8:51PM CDT
Plaza Bank (OTCBB: PLZB) purchased certain assets and assumed certain liabilities of North Las Vegas, Nevada-based 1st Commerce Bank in a purchase and assumption agreement, including loss share arrangement, with the Federal Deposit Insurance Corporation today.

Plaza Bank Earns 5-Star Rating
Marketwire - Wed Mar 27, 10:00AM CDT
Plaza Bank (OTCQB: PLZB) has received a 5-Star rating. The Bank's first such rating in its history. The designation was awarded by Bauer Financial, the nation's leading independent bank ratings agency. The 5-star rating recognizes superior performance and is evidence of consistently sound management. Plaza also received more good news as announced in The Findley Reports, which listed the Bank with a 'performer' rating.

Robert P. Gionfriddo Joins Focus Business Bank as Chief Business Banking Officer
Marketwire - Tue Mar 12, 7:00PM CDT
Focus Business Bank (OTCQB: FCSB): Focus Business Bank announced that Robert P. Gionfriddo has joined the Bank as Chief Business Banking Officer. This announcement was made by Richard Conniff, president and chief executive officer of Focus Business Bank.

Plaza Bank elects Carmen J Aguiar and Richard H Watson as chair and vice chair of its board of directors respectively
M2 - Tue Mar 05, 4:48AM CST
State chartered commercial bank Plaza Bank (OTCBB ZBW) stated on Monday that George Armendariz, the founding chairman of its board, declared the appointment the the board of Carmen J Aguiar as chair and Richard H Watson as vice chair.

Plaza Bank Names New Board Chair
Business Wire - Mon Mar 04, 4:38PM CST
Plaza Bank (OTCBB ZBW) has announced the appointment of Carmen J. Aguiar as Chair of its Board of Directors, as well as Richard H. Watson as Vice Chair. The announcement was made by George Armendariz, founding Chairman of the Board. Mr. Armendariz will remain on the Board.

Plaza Bank Announces Financial Results for the Quarter and Year Ended December 31, 2012
Marketwire - Thu Feb 21, 9:02AM CST
Plaza Bank (OTCQB: PLZB) (the "Bank" today reported unaudited net income for the fourth quarter of 2012 of $587,000, compared with net income of $443,000 in the fourth quarter of 2011. Earnings per share were $0.03, flat compared to the fourth quarter of 2011. Net interest income for the quarter was $4.3 million, up 26% compared with the prior year.

Plaza Bank names Michael V Paul as CEO and Michael J Clabby as CCO and completes executive management team
M2 - Mon Jan 07, 6:15AM CST
State chartered commercial bank, Plaza Bank (OTCBB ZBW) on Friday declared that it completed its executive management team and named Michael V (Mike) Paul as the new president and CEO and Michael J (Mike) Clabby as the new EVP and CCO, both Pacific Northwest veteran bankers with over 70 years combined commercial banking experience.

Plaza Bank Completes Executive Management Team
Business Wire - Fri Jan 04, 3:26PM CST
Plaza Bank (OTCBB ZBW) has announced the completion of its executive management team, with the naming of a new Chief Executive Officer and Chief Credit Officer, Pacific Northwest veteran bankers with over 70 years combined commercial banking experience.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 135

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 220

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 210

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 318

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 269

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 283

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 406

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 180

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 103

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 235

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading

Top 5 Most Recently Viewed Articles

Kulicke & Soffa Announces Conference Call for Fiscal Results

Updated Category News Views 122

Kulicke & Soffa Schedules Conference Call Kulicke and Soffa Industries, Inc. (NASDAQ: KLIC), a leading name in semiconductor assembly technology, has announced a conference call to discuss its third fiscal quarter financial results and business outlook. The call is set for a future date, highlighting the company's commitment to transparency and communication with its...

Continue Reading
ARMOUR Residential REIT Launches Major Stock Offering for Growth

Updated Category News Views 162

ARMOUR Residential REIT Enters Public Stock Offering ARMOUR Residential REIT, Inc. (NYSE: ARR and ARR-PRC) has officially announced an underwritten public offering of 18,500,000 shares of common stock. The company is poised to grant underwriters an additional option to purchase up to 2,775,000 shares, making this a significant move for ARMOUR as it aims to enhance its...

Continue Reading
Celebrate Mother's Day with a Unique Brunch at Cannon + Belle

Updated Category News Views 195

Cannon + Belle Offers a Memorable Mother's Day Brunch Cannon + Belle at Hilton Austin is excited to announce an elevated Mother's Day brunch that promises to create unforgettable memories. This year, the restaurant will be hosting a special brunch event aimed at honoring mothers and all they do. With an impressive menu curated by the talented Chef Gereamy Cater, guests...

Continue Reading
Figma's Shares Surge in IPO But Valuation Remains a Concern

Updated Category News Views 244

Figma's Impressive IPO Performance Figma Inc. (NYSE: FIG) has captured significant investor attention following its explosive debut in the stock market. After launching its initial public offering, the company's shares skyrocketed by over 250%, marking a remarkable milestone for the firm. The stock began trading at a price of $33 per share, leading to approximately $1.2...

Continue Reading
Journey Medical Corporation's Emrosi Launch for Rosacea Relief

Updated Category News Views 215

Journey Medical Corporation Introduces Emrosi for Rosacea Treatment Journey Medical Corporation, a key player in the dermatological pharmaceutical industry, has recently launched Emrosi™ (40 mg Minocycline Hydrochloride Modified-Release Capsules), designed for the effective treatment of rosacea. The product, featuring a unique formulation of 10 mg immediate release and...

Continue Reading